Reason for request
Modification du RCP
Modification d’AMM du 02/07/2018 : restriction de l’indication aux patients ayant une tumeur avec expression de PD-L1 ≥ 5% dans le traitement du carcinome urothélial chez les patients inéligibles au cisplatine
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
swxumENncAT5RH59
